跳至主要内容
临床试验/JPRN-UMIN000002103
JPRN-UMIN000002103已完成未知

ew Biomarkers (Lysophosphatidic Acid and Sphingosine 1-Phosphate) in Acute Coronary Syndromes at Juntendo University - J-Bacchus study

Department of Cardiovascular Medicine, Juntendo University0 个研究点目标入组 50 人开始时间: 2009年12月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who are disqualified the study by the investigators

研究者

发起方
Department of Cardiovascular Medicine, Juntendo University

相似试验

已完成
不适用
Study for biomarkers and molecular pathophysiology of Myeloproliferative disorders with eosinophilia.Hypereosinophilic syndrome, chronic eosinophilic leukemia, idiopathic eosinophilia.
JPRN-UMIN000009140Kobe University Medical School Hospital300
招募中
不适用
Study for biomarkers and molecular pathophysiology of depression diversityMajor depressive disorder
JPRN-UMIN000007825Gunma University Graduate School of Medicine80
进行中(未招募)
不适用
Profile of soluble and cellular biomarkers and of functional imaging during antiangiogenic therapies in cancer patients - PRAEMARKERAAT08The present project is an academic clinical trial in which patient suffering from hepatocellular carcinoma, non-small cell lung cancer, renal cell cancer and colorectal cancer treated routinely with antiangiogenic agents. The study protocol intends to include ten patients per tumour entitity (n=40), treated either with Sorafenib (Nexavar), Bevacizumab (Avastin) or Sunitinib (Sutent), which are all approved antiangiogenic drugs in Austria in one of the cancer types defined above.
EUCTR2008-008852-18-ATMedizinische Universität Innsbruck Innere Medizin V
招募中
不适用
Investigation of biomarkers for diagnosis and treatment of pulmonary hypertension.Pulmonary hypertension
JPRN-UMIN000032888Juntendo University50
招募中
Unknown
Analysis of phosphoinositide variants in ovarian and endometrial cancersovarian cancer, endometrial cancerD010051, D016889
JPRN-jRCT1030220526Satoh Toyomi200